source
- Expedition Therapeutics raises $115M Series B for China-sourced COPD candidateExpedition Therapeutics, a US biotech, announced a $115 million Series B financing round. The capital will be used to advance its COPD drug candidate that is being developed from a China-sourced p…
- Fecal microbiome transplant boosts peanut tolerance sixfold in early trialResearchers at Boston Children’s Hospital conducted a small open‑label phase 1 trial in which 15 adult participants received oral encapsulated fecal microbiome transplantation to test safety and ef…